Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C8H11N3O6 |
Molecular Weight | 245.1894 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2N=CC(=O)NC2=O
InChI
InChIKey=WYXSYVWAUAUWLD-SHUUEZRQSA-N
InChI=1S/C8H11N3O6/c12-2-3-5(14)6(15)7(17-3)11-8(16)10-4(13)1-9-11/h1,3,5-7,12,14-15H,2H2,(H,10,13,16)/t3-,5-,6-,7-/m1/s1
Molecular Formula | C8H11N3O6 |
Molecular Weight | 245.1894 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
6-Azauridine in combination chemotherapy of childhood acute myelocytic leukemia. | 1972 Apr |
|
Inhibitory effect of selected antiviral compounds on measles (SSPE) virus replication in vitro. | 1989 Sep |
|
Inhibition of sandfly fever Sicilian virus (Phlebovirus) replication in vitro by antiviral compounds. | 1997 Sep-Oct |
|
Antiviral activity and mode of action studies of ribavirin and mycophenolic acid against orthopoxviruses in vitro. | 2001 Nov |
|
Site specific incorporation of 6-azauridine into the genomic HDV ribozyme active site. | 2001 Oct-Nov |
|
Comparison of colorimetric, fluorometric, and visual methods for determining anti-influenza (H1N1 and H3N2) virus activities and toxicities of compounds. | 2002 Oct |
|
Use of nucleotide analogs by class I and class II CCA-adding enzymes (tRNA nucleotidyltransferase): deciphering the basis for nucleotide selection. | 2003 Aug |
|
Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. | 2003 Jun 14 |
|
Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses. | 2003 Mar |
|
A simple assay for determining antiviral activity against Crimean-Congo hemorrhagic fever virus. | 2004 Apr |
|
Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy. | 2004 Apr 5 |
|
In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-alpha and ribavirin combination. | 2004 Feb |
|
[Biotechnological synthesis of ribavirin. Effect of ribavirin and its various combinations on the reproduction of Vaccinia virus]. | 2004 Nov-Dec |
|
Synthesis of N3-substituted uridine and related pyrimidine nucleosides and their antinociceptive effects in mice. | 2005 Mar |
|
Broad-spectrum inhibitor of viruses in the Flaviviridae family. | 2005 Nov |
|
Azacytidine (Vidaza(R)) in the treatment of myelodysplastic syndromes. | 2006 Dec |
|
6-Azauracil or 8-aza-7-deazaadenine nucleosides and oligonucleotides: the effect of 2'-fluoro substituents and nucleobase nitrogens on conformation and base pairing. | 2008 Feb 7 |
|
Structure and inhibition of orotidine 5'-monophosphate decarboxylase from Plasmodium falciparum. | 2008 Mar 25 |
|
N-methylisatin-beta-thiosemicarbazone derivative (SCH 16) is an inhibitor of Japanese encephalitis virus infection in vitro and in vivo. | 2008 May 22 |
|
Antimicrobial and cytotoxic arylazoenamines. Part III: antiviral activity of selected classes of arylazoenamines. | 2008 Sep 15 |
|
Antiviral activity of indole derivatives. | 2009 Aug |
|
Transcript elongation factor TFIIS is involved in arabidopsis seed dormancy. | 2009 Feb 27 |
|
Antiviral and cytotoxic activities of aminoarylazo compounds and aryltriazene derivatives. | 2009 Jul 1 |
|
Hepatoprotective Activity of Licorice Water Extract against Cadmium-induced Toxicity in Rats. | 2009 Jun |
|
Recognition of acyl donors by lipase CAL-B in the acylation of 6-azauridine. | 2009 May-Jun |
|
Insights into arbovirus evolution and adaptation from experimental studies. | 2010 Dec |
|
Six RNA viruses and forty-one hosts: viral small RNAs and modulation of small RNA repertoires in vertebrate and invertebrate systems. | 2010 Feb 12 |
|
Historical perspectives in the development of antiviral agents against poxviruses. | 2010 Jun |
|
Triplet formation of 6-azauridine and singlet oxygen sensitization with UV light irradiation. | 2010 May 21 |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:07:40 GMT 2023
by
admin
on
Fri Dec 15 15:07:40 GMT 2023
|
Record UNII |
7BVB29RCPR
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C2170
Created by
admin on Fri Dec 15 15:07:40 GMT 2023 , Edited by admin on Fri Dec 15 15:07:40 GMT 2023
|
||
|
NCI_THESAURUS |
C1557
Created by
admin on Fri Dec 15 15:07:40 GMT 2023 , Edited by admin on Fri Dec 15 15:07:40 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
35668
Created by
admin on Fri Dec 15 15:07:40 GMT 2023 , Edited by admin on Fri Dec 15 15:07:40 GMT 2023
|
PRIMARY | |||
|
32074
Created by
admin on Fri Dec 15 15:07:40 GMT 2023 , Edited by admin on Fri Dec 15 15:07:40 GMT 2023
|
PRIMARY | |||
|
200-199-6
Created by
admin on Fri Dec 15 15:07:40 GMT 2023 , Edited by admin on Fri Dec 15 15:07:40 GMT 2023
|
PRIMARY | |||
|
7BVB29RCPR
Created by
admin on Fri Dec 15 15:07:40 GMT 2023 , Edited by admin on Fri Dec 15 15:07:40 GMT 2023
|
PRIMARY | |||
|
C291
Created by
admin on Fri Dec 15 15:07:40 GMT 2023 , Edited by admin on Fri Dec 15 15:07:40 GMT 2023
|
PRIMARY | |||
|
SUB197079
Created by
admin on Fri Dec 15 15:07:40 GMT 2023 , Edited by admin on Fri Dec 15 15:07:40 GMT 2023
|
PRIMARY | |||
|
100000182789
Created by
admin on Fri Dec 15 15:07:40 GMT 2023 , Edited by admin on Fri Dec 15 15:07:40 GMT 2023
|
PRIMARY | |||
|
3206
Created by
admin on Fri Dec 15 15:07:40 GMT 2023 , Edited by admin on Fri Dec 15 15:07:40 GMT 2023
|
PRIMARY | |||
|
m2167
Created by
admin on Fri Dec 15 15:07:40 GMT 2023 , Edited by admin on Fri Dec 15 15:07:40 GMT 2023
|
PRIMARY | Merck Index | ||
|
5901
Created by
admin on Fri Dec 15 15:07:40 GMT 2023 , Edited by admin on Fri Dec 15 15:07:40 GMT 2023
|
PRIMARY | |||
|
D001380
Created by
admin on Fri Dec 15 15:07:40 GMT 2023 , Edited by admin on Fri Dec 15 15:07:40 GMT 2023
|
PRIMARY | |||
|
54-25-1
Created by
admin on Fri Dec 15 15:07:40 GMT 2023 , Edited by admin on Fri Dec 15 15:07:40 GMT 2023
|
PRIMARY | |||
|
DTXSID20960091
Created by
admin on Fri Dec 15 15:07:40 GMT 2023 , Edited by admin on Fri Dec 15 15:07:40 GMT 2023
|
PRIMARY |